What does Dr. Alexandra Kluyskens - MKA do?

Dr. Alexandra Kluyskens - MKA is a specialist medical practice in Sint-Martens-Latem. Private Limited, started on 3 February 2022, 1 establishment.

What is the address of Dr. Alexandra Kluyskens - MKA?

The registered office of Dr. Alexandra Kluyskens - MKA is located at Lindenpark 27, 9831 Sint-Martens-Latem.

Is Dr. Alexandra Kluyskens - MKA still active?

Yes. According to the CBE (29 October 2026) Dr. Alexandra Kluyskens - MKA is active, legal situation “Normale toestand”, started on 3 February 2022.

Is Dr. Alexandra Kluyskens - MKA registered on Peppol?

Yes, Dr. Alexandra Kluyskens - MKA is registered on the Peppol network with ID 0208:0781559484.

What is the enterprise number of Dr. Alexandra Kluyskens - MKA?

The enterprise number of Dr. Alexandra Kluyskens - MKA is BE0781559484.

When was Dr. Alexandra Kluyskens - MKA founded?

Dr. Alexandra Kluyskens - MKA was founded on 3 February 2022.

Who are the directors of Dr. Alexandra Kluyskens - MKA?

According to the 2025 annual accounts, the directors of Dr. Alexandra Kluyskens - MKA are: Alexandra Kluyskens.

Is Dr. Alexandra Kluyskens - MKA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 February 2022; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Alexandra Kluyskens - MKA make in 2025?

Dr. Alexandra Kluyskens - MKA posted a profit after taxes of € 387,563 in financial year 2025.

What is the revenue of Dr. Alexandra Kluyskens - MKA?

As a small company, Dr. Alexandra Kluyskens - MKA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 528,622.

Dr. Alexandra Kluyskens - MKA (Private Limited)

Dossier Dr. Alexandra Kluyskens - MKA, printed on 29 October 2026 from databakkes.be/en/0781559484/dr-alexandra-kluyskens-mka. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Alexandra Kluyskens - MKA from Sint-Martens-Latem, company number BE0781559484, closed financial year 2025 with a result of € 387,563 after tax. For that financial year Dr. Alexandra Kluyskens - MKA recorded a gross margin of € 528,622 and equity of € 416,784. Compared with financial year 2024, the result moved from € 12,452 to € 387,563. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2026.

What it is worth Growing

€ 416,784

▲ € 375,111 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 387,563

▲ € 375,111 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 166,000

▲ € 143,529 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 12,452 paid out

3 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 28,795

▼ 21% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 925

▼ 61% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 56,428

▲ € 46,179 vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 17,793 Gross margin 2022: € 17,793 First fiscal year in the series	€ 29,598 Gross margin 2023: € 29,598 ▲ 66% vs 2022 (€ 17,793) Favourable step	€ 30,084 Gross margin 2024: € 30,084 ▲ 2% vs 2023 (€ 29,598) Favourable step	€ 528,622 Gross margin 2025: € 528,622 ▲ € 498,538 vs 2024 (€ 30,084) Favourable step	▲ € 498,538
Profit after taxes	€ 12,599 Profit after taxes 2022: € 12,599 First fiscal year in the series	€ 11,622 Profit after taxes 2023: € 11,622 ▼ 8% vs 2022 (€ 12,599) Unfavourable step	€ 12,452 Profit after taxes 2024: € 12,452 ▲ 7% vs 2023 (€ 11,622) Favourable step	€ 387,563 Profit after taxes 2025: € 387,563 ▲ € 375,111 vs 2024 (€ 12,452) Favourable step	▲ € 375,111
Equity	€ 17,599 Equity 2022: € 17,599 First fiscal year in the series	€ 29,221 Equity 2023: € 29,221 ▲ 66% vs 2022 (€ 17,599) Favourable step	€ 41,673 Equity 2024: € 41,673 ▲ 43% vs 2023 (€ 29,221) Favourable step	€ 416,784 Equity 2025: € 416,784 ▲ € 375,111 vs 2024 (€ 41,673) Favourable step	▲ € 375,111
Total debts	€ 90,250 Total debts 2022: € 90,250 First fiscal year in the series	€ 38,141 Total debts 2023: € 38,141 ▼ 58% vs 2022 (€ 90,250) Favourable step	€ 19,156 Total debts 2024: € 19,156 ▼ 50% vs 2023 (€ 38,141) Favourable step	€ 57,353 Total debts 2025: € 57,353 ▲ 199% vs 2024 (€ 19,156) Unfavourable step	▲ 199%
Cash	€ 43,497 Cash 2022: € 43,497 First fiscal year in the series	€ 14,731 Cash 2023: € 14,731 ▼ 66% vs 2022 (€ 43,497) Unfavourable step	€ 22,470 Cash 2024: € 22,470 ▲ 53% vs 2023 (€ 14,731) Favourable step	€ 166,000 Cash 2025: € 166,000 ▲ € 143,529 vs 2024 (€ 22,470) Favourable step	▲ € 143,529
Retained profit	€ 12,599 Retained profit 2022: € 12,599 First fiscal year in the series	€ 24,221 Retained profit 2023: € 24,221 ▲ 92% vs 2022 (€ 12,599) Favourable step	€ 36,673 Retained profit 2024: € 36,673 ▲ 51% vs 2023 (€ 24,221) Favourable step	€ 411,784 Retained profit 2025: € 411,784 ▲ € 375,111 vs 2024 (€ 36,673) Favourable step	▲ € 375,111
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 12,452 Dividend 2025: € 12,452 Unchanged (€ 0) Unchanged
Balance sheet total	€ 107,849 Balance sheet total 2022: € 107,849 First fiscal year in the series	€ 67,362 Balance sheet total 2023: € 67,362 ▼ 38% vs 2022 (€ 107,849) Unchanged	€ 60,829 Balance sheet total 2024: € 60,829 ▼ 10% vs 2023 (€ 67,362) Unchanged	€ 474,137 Balance sheet total 2025: € 474,137 ▲ € 413,308 vs 2024 (€ 60,829) Unchanged	▲ € 413,308

Key figures of Dr. Alexandra Kluyskens - MKA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Alexandra Kluyskens - MKA?

What happened at Dr. Alexandra Kluyskens - MKA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2026 New annual accounts for financial year 2025: profit of € 387,563 (▲ € 375,111 vs 2024). filed late Source: NBB ↗
Feb 3, 2022 New establishment in Sint-Martens-Latem. KBO
Feb 3, 2022 Start of the company according to the CBE. KBO
2022 Alexandra Kluyskens became a director. NBB

In short

From € 12,599 profit in 2022 to € 387,563 profit in 2025.

Paid € 140,419 in corporate taxes since 2022.

Best year ever: 2025, with € 387,563 profit.

Paid out € 12,452 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Alexandra Kluyskens

Dr. Alexandra Kluyskens - MKA

Behind Dr. Alexandra Kluyskens - MKA is Alexandra Kluyskens.

Directors

According to the 2025 annual accounts

Alexandra Kluyskens

Director

since 2022

Establishments

Establishment units

Physical locations of this company

Registered office

Lindenpark 27

9831 Sint-Martens-Latem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

AUCLEM

€ 187,135 gross margin · 2025

MZN

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0781.559.484
VAT number: BE 0781.559.484
Registered office: Lindenpark 27, 9831 Sint-Martens-Latem
Names & denominations: Dr. Alexandra Kluyskens - MKA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 February 2022
Peppol: Active · Active since 16 Dec 2025
Contact: [email protected]
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗